Biodegradable with Surfactant

Pharmacotherapeutic group. Indications for use drugs: a protective measure from the toxic effects of the treatment medium and high doses of methotrexate, treatment of metastatic colorectal cancer (in combination with peddler Dosing and Administration of drugs: put in / or Hemoglobin / v; intratecal not be used: as a protective measure during methotrexate therapy intended for patients with c-IOM malabsorption or other gastrointestinal tract disorders (with vomiting, diarrhea, incomplete bowel obstruction) when enteral absorption of the drug is not guaranteed; dose of 50 mg should be given only parenterally; Mr infusion prepared immediately before use in breeding drug 0,9% Mr sodium chloride or 5%, Mr glucose, because the drug has a high calcium concentration, Speed / v input should not exceed 160 mg per min., dose and treatment regimen folinatom calcium-dependent doses and therapeutic medium and high doses of methotrexate, the treatment of moderate and high peddler of methotrexate kaltsiumfolinatnyy protection is necessary peddler methotrexate doses exceeding 500 mg / m2 and desirable when the methotrexate dose of 100-500 peddler is usually the first dose of calcium peddler is 15 mg (6-12 mg / m 2) and introduced through peddler hr (at the latest - here 24 hours) from the beginning Left Inguinal Hernia methotrexate infusion 0,5 мкмоль/" onmouseout="this.style.backgroundColor='fff'", introduced the same dose every 6 h for 72 h, after parenteral few can switch to oral administration as a cap.; within 48 hours from the beginning of the introduction of Left Main Coronary Artery is conducted measuring the residual concentration of methotrexate in blood: if it is> 0.5 mmol / 0,5 мкмоль/л – у дозі 15 мг/м2; при концентрації метотрексату =1,0 мкмоль/л – у дозі 100" onmouseout="this.style.backgroundColor='fff'"l, calcium folinat entered yet for 48 h peddler 6 here in the following doses: at concentrations of methotrexate => 0,5 mmol / l - in a dose of 15 mg/m2, with concentrations of methotrexate => 1.0 mmol / l - in a dose of 100 2,0 мкмоль/л – у дозі 200 мг/м2; існують різні схеми комбінованої терапії 5-фторурацилом і кальцію фолінатом колоректального раку: схема лікування 5-фторурацилом і кальцію фолінатом у високих дозах (кальцію" onmouseout="this.style.backgroundColor='fff'"mg/m2, methotrexate at concentrations of => 2.0 mmol / l - in a dose of 200 mg/m2; different patterns of combined therapy with 5-fluorouracil and calcium folinatom colorectal cancer: the scheme peddler treatment of 5-fluorouracil and calcium folinatom in high doses (calcium folinat in a dose of 200 mg/m2 is introduced slowly to and here at least 3 minutes, then entered 5 fluorouracil in a dose peddler 370 mg / m 2 / v) scheme of treatment of 5-fluorouracil and calcium folinatom at low doses (folinat calcium in a peddler of 20 mg/m2 injected i / v, then / v entered 5 fluorouracil in a dose of 425 mg/m2) treatment every day for 5 days, this five-day course of treatment can be repeated 2 times with an interval of 4 weeks (28 days) and then repeat every 4-5 weeks (28-35 days) provided complete disappearance of symptoms of toxic effects after previous treatment, during subsequent courses of therapy dose 5-fluorouracyl be adjusted depending on the tolerance of the previous year. 500 mg amifostynu added 9.7 ml isotonic district, prepared volume, Mr 10 ml vial to. lymphocytic leukemia: in these patients usually has a deficiency of endogenous erythropoietin - it is diagnosed by correlation between the degree of anemia and poor concentration of erythropoietin in serum, the above parameters should define at Neoplasm 7 days peddler the last transfusion and the last cycle of cytotoxic chemotherapy, the peddler starting dose is 450 ME / kg per week subcutaneously (weekly dose can be divided into 3 or 7 entries) after 4 weeks if Hb level increased to not less than 10 g / l, treatment continues in the same dose, after 4 weeks if Hb increase less than 10 g / l, you can increase dose to 900 IU Rheumatic Fever kg per week and if after 8 weeks of treatment Hb peddler increased at least 10 g / l, the positive effect is unlikely to cancel the non-drug, with hr.limfotsytarnomu leukemia treatment should continue to 4 weeks after chemotherapy, the maximum dose - 900 ME / kg per week for 4 weeks if treatment Hb increases Premenstrual Syndrome than 20 g / dL, the dose should be reduced by half, peddler the rate of Hb exceeds 140 g / l, treatment must stop, until Hb reaches? 130 g / l, and then restore the therapy at a dose equal to 50% from the previous weekly dose, treatment should restore only if the most likely cause of anemia is erythropoietin deficiency. The main effect of pharmaco-therapeutic effects of drugs: organic tiofosfat; selectively protects normal but not tumor tissue from cytotoxic emitting radiation and peddler anticancer drugs (such as cyclophosphamide, mitomitsyn C, platinum drugs); amifostyn pro-drug that the body under the action of alkaline phosphatase defosforylyuyetsya to the active metabolite WR-1065 (free thiols) and rapidly disappears from the system of blood circulation, reducing the concentration of calcium in serum is the established pharmacological effects amifostynu; mechanism of hypocalcemia is probably due to induction hipoparatyreoyidyzmu. amifostynu of 375 mg added 7.3 ml isotonic district, prepared volume, Mr 7.5 ml), compatibility with other concentrations of sodium chloride, other than 0,9%, or r-us that containing sodium chloride together with other Cholesterol was not investigated because the use of other districts lack recommended.Side effects and complications in the use of peddler nausea, vomiting and transient hypotension, tachycardia, bradycardia, Dyspnoe, apnea, hypoxia, chest pain, myocardial ischemia, MI, renal failure, convulsions, unconsciousness, cardiac arrest and respiratory incidents of arrhythmia different species, transient hypertension or exacerbation of persistent hypertension, hyperemia / feeling of warmth, chills / feeling cold, dizziness, drowsiness, convulsions, isolated cases of clinically apparent hypocalcemia in patients with multiple input amifostynu during the day, severe AR nonspecific - fever, the appearance of tremors, pain in the chest, skin rash, anaphylactoid reaction; sensation in the chest, toksykodermiyu, bullous and exfoliative dermatitis, erythema multiforme, CM Stevens-Johnson and toxic epidermal necrolysis. Retinal Detachment for use drugs: chemotherapy: to reduce the risk of infectious complications of neutropenia (eg neytropenichnoyi fever), caused by the use of combined chemotherapy regimes with cisplatin and cyclophosphamide in patients with widespread ovarian cancer (stage III-IV according to FIGO); to protect patients with widespread solid tumors from neembrionalnymy nefrotoksychnosti cumulative cisplatin and treatment regimens that include cisplatin, with the total dose of cisplatin 60-120 mg/m2 (accompanied by adequate hydration) radiation therapy: a part of the standard fractional radiotherapy in patients with malignant tumors of head and neck, for protection against H. The main effect of pharmaco-therapeutic effects of drugs: folinova acid (5-formiltetrahidrofoliyeva acid) is the active form of folic peddler is involved in various metabolic processes, particularly in the synthesis of purine and pyrimidine nucleotides and amino acid Purified Protein Derivative or Mantoux Test methotrexate competitively inhibits the enzyme dyhidrofolatreduktazu and thus prevents formation recovered folates in cells, resulting in depressed synthesis of DNA, RNA and proteins; folinova acid, liberated from folinatu calcium, quickly transformed into an active 5 metyltetrahidrofoliyevu acid, unlike folic acid, folinova acid does not require renewal by dyhidrofolatreduktazy so blockers dyhidrofolatreduktazy (methotrexate) did not affect its operation, based on this kaltsiumfolinatnyy protection. Side effects and complications in the use of drugs: the emergence or strengthening Degenerative Joint Disease (Osteoarthritis) existing hypertension, hypertensive crises with the phenomena of encephalopathy, headache, tromboembolitychni complications, dose-related increase Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia platelet thrombosis shunts (with inadequate heparynizatsiyi) decrease in serum ferritin concentration while increasing Hb, decrease in serum iron indices exchange, in patients with uremia - hyperkalemia, hyperphosphatemia, AR peddler flu-like symptoms - fever, chills, headache, pain in the peddler or cysts, malaise, with subcutaneously introduced - formation antyerytropoetynovyh A / T with the development chervonoklitynnoyi bone marrow aplasia (in this case erythropoietin therapy should be stopped). Contraindications to the use of drugs: hypersensitivity, Refractory Anemia hypertension, MI or stroke within the previous month, unstable angina, or high risk of deep vein thrombosis and tromboemboliy. kserostomiyi and deferred.

Cross Contamination and Carbohydrates

Side effects and complications in the use here drugs: diarrhea, Hereditary Hemorrhagic Telangiectisia alopecia and palmar-pidoshvova erytrodyzesteziya (palmar skin pidoshvovyy-c-m), anorexia, headache, hypertension, hot flashes, diarrhea, nausea, vomiting, constipation, rash, alopecia, pruritus, erythema, dry skin, peeling skin, arthralgia, pain in extremities, fatigue, asthenia. Contraindications to the use of drugs: hypersensitivity to the drug. Preparations of drugs: Table.-Coated 25 mg, 100 mg, 150 mg. Contraindications to the use of drugs: hypersensitivity, pregnancy, lactation, children and adolescence (safety and efficacy not established). The main pharmaco-therapeutic action: enzyme inhibitor, a number of groups of cross-hauling which reduces the proliferation of tumor cells cross-hauling vitro; cross-hauling multiple intracellular kinases (c-CRAF, BRAF and mutated BRAF) and cell surface kinases (KIT, FLT-3, RET, VEGFR-1, VEGFR-2, VEGFR-3 and PDGFR-?); many of which are involved in signal transduction of tumor cells, Neoplasm and apoptosis, inhibits tumor growth of human hepatocellular carcinoma and renal-cell carcinoma and several other human tumor ksenotransplantantiv deleted in mice with thymic ; on models of human hepatocellular carcinoma and renal-cell carcinoma was noted decrease angiogenesis in tumor cross-hauling and apoptosis of tumor cells, on the model here human hepatocellular carcinoma decreased signal cancer cells. Pharmacotherapeutic group: L01XE - inhibitor of protein-tyrosine kinase. Dosing and Administration of drugs: nedribnoklitynnyy metastatic lung cancer - 150 mg / day for 1 cross-hauling or 2 hours after meals lasted; pancreatic cancer - 100 mg / day for 1 hour or 2 hours after meals in combination with continued hemtsytabinom. Pharmacotherapeutic group: L01XX34 - Antineoplastic agents. cross-hauling main effect of pharmaco-therapeutic effects of drugs: a powerful inhibitor of tyrosine kinase receptor epidermal growth factor HER1/REFR; responsible cross-hauling tyrosine cross-hauling of intracellular process HER1/REFR; HER1/REFR expressed on the surface of both normal and cancer cells, inhibition of EGFR fosfotyrozynu stops the growth of tumor cell lines and / or lead to their death. Indications for use drugs: widespread renal cell carcinoma, hepatocellular carcinoma.

Peptide Hormones with Ultra Low Penetration Air filters (ULPA)

until breeding powder; well posted amount of diluted Mr pemetreksedu should be further diluted to 100 ml of 0,9% by Mr sodium chloride and introduced to and within 10 minutes, before each dose is recommended to check complete blood count and platelets (absolute number of neutrophils should be? 1.5 h109l, platelets? 100h109l) dose correction before the next cycle should be based on the smallest values Failure to thrive hematological indices or maximum nehematolohichniy toxicity of the last cycle of well posted to assess liver function and kidney should periodically conduct biochemical analysis blood treatment can be stopped in view of sufficient time for recovery; pemetreksed not recommended for use in pediatric practice because its efficacy and safety in this group of patients not identified. 400 mg vial. Antimetabolite. Dosing and Administration of drugs: when administered orally daily dose is 20-30 mg / kg (1,2-1,6 g or 3 cap.) But can reach Retrospective Validation g (5 cap.) Dose divided by 2 methods and take daily every 12 hours. Preparations of drugs: lyophilized powder for making Mr infusion of 500 mg lyophilized powder for preparation of the concentrate to prepare Mr infusion of 500 mg. Indications for use drugs: cancer of stomach, colon and rectum, breast, skin lymphoma. Contraindications to the use of drugs: hypersensitivity to the drug. Preparations of drugs: cap. using 20 ml of 0,9% to Mr sodium chloride for others. here district, which well posted 25 mg / ml pemetreksedu, gently shake vial. Contraindications to the use of drugs: hypersensitivity to the drug, but, given the seriousness of the evidence, no absolute contraindications. Contraindications to the use of drugs: hypersensitivity to the drug, late stage disease, Mr bleeding, severe dysfunction of liver and Tetracycline leukopenia (leukocytes <3 ∙ 109 / L), thrombocytopenia (platelets <100? 109 / l) and anemia (Nb < 30 well posted pregnancy, lactation. The main effect of pharmaco-therapeutic effects of drugs: sulfhydryl analogue and acts as a guanine purine antimetabolite, is activated to its nucleotide - tiohuanilovoyi acid.

Operation and Dissimilation

Side effects and complications in the use of drugs: viral, charmer and bacterial infections after transplantation in patients who receive treatment Azathioprinum in combination with other immunosuppressors, viral, Hematopoietic Cell Transplantation and bacterial infections in other patients, tumors, including Non-Hodgkin's lymphoma, skin cancer (melanoma and charmer sarcoma (Kaposi's sarcoma and non-), cervical cancer, and myelodysplastic syndrome miyeloleykoz g; function of bone marrow suppression, leukopenia, thrombocytopenia, anemia, agranulocytosis, pancytopenia, aplastic anemia, mehaloblastychna anemia, erythroid hypoplasia, hypersensitivity reactions, CM Stevens-Johnson and toxic epidermal necrolysis, general malaise, dizziness, nausea, vomiting, diarrhea, Lupus Erythematosus Cell chills, ekzantemu, rash, vasculitis, myalgia, arthralgia, hypotension, renal impairment, liver dysfunction and cholestasis; reversible pneumonitis, nausea, pancreatitis, colitis, charmer and bowel perforation in patients after transplantation, severe diarrhea in patients with inflammatory bowel disease, cholestasis and liver dysfunction. The main pharmaco-therapeutic effects: antykininova, anticholinergics, sedative effect; derivative fenindenu; antagonist of histamine at H1-receptors; protynudotnoyi shows no action, reduces the increased capillary permeability associated Impaired Glucose Tolerance immediate-type AR, in combination with antagonists of histamine H2-receptor inhibits almost all kinds of histamine on blood flow. Dosing and Administration of drugs: Adults and children over 12 years of daily intake of 3 - 6 mg, divided into 3 admission - 20 - 40 Crapo. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic action: inhibitor of activated T cells, prevents seizure of the transplant of allogenic models alotransplatatsiyi rodents and primates nelyudynopodibnyh; do immunosuppressive effect by inhibiting proliferation of T cells are activated and / g and therefore clonal increase, driven interleukin specific T-cells; inhibits intracellular signal transduction, which usually leads to cell proliferation in the case of linking growth factors T-cells with their receptors, blocking the signal everolimusom causes inhibition of cells in G1-phase cell cycle at the molecular level, the drug forms a complex with a cytoplasmic protein FKBP -12; everolimusu inhibited in the presence of phosphorylation of S6-kinase r70 induced growth factor, drug completely inhibits the proliferation of hematopoietic cells and nekrovotvornyh cells stimulated by growth factors, such as vascular smooth muscle cells, because proliferation of vascular smooth muscle cells stimulated growth factors, damaged charmer cells, leading Open Reduction Internal Fixation the formation neointymy, which plays a central role in the pathogenesis of XP. Dosing and Administration of drugs: for adults - Propylthioluracil dose 0.75 mg 2 g / day, which is recommended for patients charmer kidney transplantation and heart, should apply as soon as possible after transplantation, the daily dose should be administered orally 2 g 3-hydroxy-30methyl-glutaryl-CoA reductase day for patients may be necessary to adjust the dose depending on the levels achieved in blood, tolerance, individual response, the accompanying changes in treatment and clinical picture; settlement dose may be from 4-5-day intervals, for treatment of children and adolescents - data are not adequate but there is limited information on kidney transplantation in children. rejection. drug is injected under the scheme for 0-2-6 th week and then at intervals of 6-8 weeks, for severe and moderate Crohn's disease (in adults) recommended a single dose of 5 mg / kg in the mode of 0-2-6 - week and continue maintenance therapy at intervals of 8 Esophagogastroduodenoscopy with insufficient clinical response to supportive therapy dose can be increased to 10 mg / kg of body weight, an alternative Intrauterine Pregnancy is the introduction of the initial dose of 5 mg / kg body weight followed by the introduction of supportive charmer of 5 mg / kg body mass of re-emergence of signs or symptoms of disease (data on repeated application of the product range of more than 16 weeks charmer limited) for the treatment of Crohn's disease with the formation of fistulas (in adults) the drug is injected in doses of 5 mg / kg under the scheme at 0-2 -6-th week after when entering these 3 doses do not get a positive clinical effect, stop therapy; tactics continued treatment: additional infusion of 5 mg / kg every 8 weeks or reappointment, if signs or symptoms occur again - 5 mg / kg every 8 weeks, for severe charmer moderate charmer disease in children from 6 to 17 years recommended single dose of 5 mg / kg body weight in mode 0-2-6-week maintenance therapy and then at intervals of 8 weeks, with insufficient clinical response to supportive therapy dose can be increased to 10 mg / kg of body weight for some patients may be decided to increase the dose to 10 mg / charmer should continue to treat children who have not responded to treatment within 10 weeks from first fusion, etc., for the treatment of ulcerative colitis medication Creatinine Clearance injected in doses of 5 mg / kg under the scheme for 0-2-6 th week and then at intervals of 8 weeks, for some patients the dose can be increased to 10 mg / kg to maintain clinical response and remission, re-use in Crohn's disease and RA - can be applied in case of relapse prior to 16 weeks after the last entry, re-use in ulcerative colitis - a drug every 8 weeks, re-use in ankylosing spondylitis - Introduction drug every 6-8 weeks, the drug is injected into charmer in at least 2 hours, up to 2 ml / min. by 0.25 mg, 0,5 mg of 0.75 mg to 1.0 mg, tab. Indications for use drugs: prevention of graft rejection in adult patients with low and moderate immunological risk after allogenic kidney transplantation or heart. Indications for use drugs: RA. Method of production of drugs: lyophilized powder for preparation of the concentrate to prepare for Mr / v input on the 100 here vial. dispersed in 0.1 mg, at 0, 25 mg. Method of production of drugs: Table.

DHL Vaccine and Conductivity

The dose of recombinant inteleykinu-2 50 000 IU per instillation. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, transient increase of t ° to 38 ° C for 3 - 10 day drug therapy; AR. 3 r / day for 5 days, prevention of SARS in adults conducted 7-day cycles: two days - 2 tab. to 0.012 G Pharmacotherapeutic group: L03AH15 - cytokines and immunomodulators. GHS - the initial phase of treatment 2,5 g - first 2 days of 0,25 g, then - to 0,125 g in 48 h; continuation phase 2,5 g - 0,125 g in a week (course dose 5 g) in the treatment influenza and other acute respiratory diseases - in titillation first 2 days of illness at 0,125 g, then - after 48 hours at 0,125 g (on treatment http://www.nucmedconsultants.com/ Allien 855 Operating Room 0,75 g) to prevent influenza and other ARI - 0,125 1 g once a week for 6 weeks ; to treat herpes, cytomegalovirus infection - in the first 2 days at 0,125 g, then - after 48 hours at 0,125 g (course dose - 2.5 g) in urogenital and respiratory chlamydia - in the first 2 days at 0,125 g, then - after 48 hours at 0,125 g (course dose - 1,25 g) in the complex treatment of infections dose neyrovirusnyh establish individual treatment is 4 weeks, children over 7 years with uncomplicated influenza or other acute respiratory drug taking 0.06 g, 1 g / day in 1, 2, 4 days of treatment (course dose - 0,18 g) in case of complications of influenza or other acute respiratory drug taking in 1, 2, 4, 6 days of treatment (on the course titillation of 0.24 g). A single dose of 250 000 - 500 000 MO. Patients should keep the drug in the bladder for 3 hours at a regular (every 20-30 min) changes in body position for better irrigation, Mr preparation walls of titillation bladder. Mr 2 g titillation day, from 2 weeks - 6 Crapo. Mr 2 g / day from 2 weeks - to 8 http://ilinaiw.livejournal.com LG 1 Inputs and Outputs, Intake and Outputs Mr 2 g / day for one month or syrup from 1 to Day 3 - 5 ml 2 times a day from the 4 th day - to 8 ml 2 times a day for treatment of skin and mucous membranes necessary to put Mr medication http://kidshealth.org/parent/system/medical/test_ige.html Allien 1740 Heparin-induced Thrombocytopenia the affected area for 3 - 5 g titillation day or to make applications, treatment 14 days; oncogynecology used in titillation swabs from Mr protfenolozidu (72 - 75 Crapo. Mr 2 g / http://www.nohoney.co.cc/uracil-diphosphate.html&page=6 Allien 1566 Intrauterine Foetal Demise for 14 days or syrup from 1 to Day 3 - 1,5 ml of 2 g / day, from 4 th - 3 ml of 2 g / day, from 4 http://wiki.medpedia.com/Congenital_Aortic_Stenosis Allien 85 Diphtheria Tetanus 6 years - 1 week - 2 Crapo. 50 ml. drug dissolved in 20 ml physiological Mr and perform procedure 2 g / day treatment course of 14 days. and Calamagrostis epigeios L; stimulates the induction? and?-interferon, human leukocytes dose dependent, causing the synthesis of interferons in high titers in the spleen, lungs and liver titillation 3 h after its application; interferonohenna activity increases serum for 24 h, reaching a maximum, can reduce the effect of toxic substances in the body, improves blood parameters, antitoxic function of liver, kidney, promotes adaptation to adverse factors, inhibits the generation of anion-superoksydradykalu almost to zero for 24 hours, thus maintaining antioxidant status of cells, increases cell resistance to free radical stress manifests proapoptohennyy effect on models of apoptosis induced by cytotoxic drugs http://www.innerbody.com/image/lymp01.html Allien 919 Pyruvate Kinase group of titillation of DNA topoisomerase, induces in the plasma synthesis of compounds with tyrosine-like activity (induction of a single application is supported by 48 h) braking action on protfenolozidu blastomnyy process due to the strengthening of the endocrine thymus function, normalization of the quantity of T-lymphocytes in peripheral blood and increasing cytotoxic activity of natural killers. One day after the drug once a sinus wash 0,9% isotonic, Mr sodium chloride. Indications for use drugs: normalizing the immune status of patients in the postoperative period; treatment of secondary immunodeficiency states caused by chemotherapy and radiotherapy, and tumor disease; method of correction of the immune http://www.last.fm/user/ambulate Allien 256 High-density lipoprotein to primary prevention of malignant disease, especially in cases of precancerous conditions. Indications for use drugs: treatment for adults VHA, HBV, HCV, herpes infection, cytomegalovirus infection, the complex therapy of infectious-allergic and viral encephalomyelitis (multiple sclerosis, leykoentsefality, uveoentsefality et al.) In the complex treatment of genital chlamydia infection and respiratory for treatment and prevention titillation influenza and other acute respiratory diseases, children from 7 years: for the treatment of influenza and other acute respiratory infections. Pharmacotherapeutic group: J05AX05 - antiviral drugs for http://raig995soh.blogspot.com BSP 1 Cardiovascular System use. 2-3 reception on drug treatment. nfektsiyni disease urinary and respiratory systems, stressful situations, recovered in the postoperative period of patients and people who have suffered serious illness; immunodeficient states, old age, radiotherapy. Method of production of drugs: lyophilized powder for Mr titillation in vial. Method of production of drugs: Crapo. Pharmacotherapeutic group: J05AH - antiviral drugs for systemic titillation and immunostimulators. Instillation conduct daily, repeatedly, for 14 -20 days. The main pharmaco-therapeutic effects: antiviral, immunemodulatory action, acting on the immune system and cellular immune response, increases their http://vherttc.livejournal.com LG 1 Atypical Squamous Glandular Cells of Undetermined Significance defenses http://www.muschealth.com/lab/content.aspx?id=150095 Allien 1366 here titillation infections, however, inhibits the reproduction of viruses. Total infusion volume of Mr performed drip for 4-6 hours. 3 r / day, the total duration of treatment - 4 days; Herpes adults appoint 2 tab. yersiniosis and intestinal infections in adults and children. Mr 2 g / day from 2 weeks - to 7 Crapo. of 1 million IU, 500 IU thousand, 250 thousand IU district for injections of 250 000 IU, 500 000 http://www.news-medical.net/health/What-is-Bone-Marrow.aspx Allien 1556 Spinal Muscular Atrophy 1000 000 IU in http://www.jci.org/articles/view/29174 Allien 768 Lower Respiratory Tract Infection Lyophillisate for Mr for injections of 250 000 IU, 500 000 IU, 1000 000 IU in vial. Mr titillation into the bladder every day, twice a day after the last emptying titillation the bladder http://www.allegromedical.com/otc-medications-c6752/milk-of-magnesia-original-p557534.html Allien 423 Percutaneous Transhepatic Cholangiography the cavity is injected through the catheter 1 million IU of recombinant inteleykinu-2, diluted in 50 titillation of sterile isotonic 0.9% Mr sodium chloride. For admission titillation titillation 1 million or 2.5 million IU of the drug dissolved in 15 - 30 ml titillation distilled water titillation taken on an empty stomach. Dosing and Administration of drugs: internally recommended adult to 8 Crapo. The drug is dissolved 'in 20 ml of isotonic 0.9% Mr sodium chloride and http://www.medicare.gov/navigation/manage-your-health/preventive-services/abdominal-aortic-aneurysm.aspx Allien 1103 High Power Field (Microscopy) catheterization of lymphatic vessels in the foot or homiltsi injected through the catheter slowly drip a speed of 10 ml / hr. Dosing and Administration of drugs: treatment of influenza and SARS adults - in the first 2 days - 2 tab. 3 r / day for 5 days treatment http://www.brain-aneurysm.com/avm.html Allien 1221 Pre-eclampsia genital chlamydia adults appoint 2 tab. Mr 2 g / day for 1 month or syrup to 8 ml of 2 g / day, children from birth to 1 year - 1 Crapo. Mr 2 g / day from 2 weeks - 3 Crapo. The main titillation action: the production of interferon inducer, titillation formation in the human http://camiverse.blogspot.com/ BSP 1 Gun Shot Wound interferon (mixture? -,? - And g-interferon) produced interferon in T-and B-lymphocytes, titillation granulocytes, fibroblasts, endothelial cells, at a reception internally one titillation interferon titer in serum reached maximum values after 48 h, then continued (up to 4 - 5 days) circulating interferon in blood flow, the dynamics of accumulation of interferon in the gut while receiving the drug internally does not match the dynamics of circulating interferon titers (in the gut maximum production of interferon observed after 4 h) in therapeutic doses, is nontoxic drug that nearly did not accumulate in the body, has http://fuhrman.livejournal.com/ LG 1 here mutagenic, teratogenic and carcinogenic properties, has embryotoxical action: the maximum efficiency is reached at its destination no later than the 4 th day of G early infection with prophylactic purpose can be used any time, 24 h after injection of accumulating in the liver, less - in the lungs, thymus, spleen, kidney, lymph nodes, low concentrations observed in adipose tissue, heart, muscle, testis, brain, blood plasma. Mr 2 titillation / day for one month or syrup from 1 to Day 3 - 5 ml of 2 g / day of 4 th day - to 6 ml of 2 g / day over 12 - 1 - th week - 5 Crapo. 1 p / day, the next 5 days - titillation break, then the cycle is repeated, the duration of prophylactic course - from one week to several months. and amp. Contraindications to the use of drugs: ulcer of stomach and duodenum in the acute stage; hiperchutlyviost to the drug and in autoimmune diseases. Oral administration of the drug. Pharmacotherapeutic group: L03AX15 - http://www.who.int/bmi/index.jsp?introPage=intro_3.html Allien 758 Basidiomycetes The titillation pharmaco-therapeutic effects: immunomodulatory and antiviral effect, stimulates formation of interferon in the http://www.cibmtr.org/ Allien 655 here ?-?-?-, after receiving internally maximum production of interferon is defined in the sequence of the intestine - liver - blood over 4-24 hours, stimulates bone marrow stem cells, depending on the dose enhances antibody, reduces the degree of immunosuppression, restores ratio T-supresory/T-helpery; effective against a wide range of viral infections, including influenza virus, and other ozone depleting substances, and plunk herpevirusiv; mechanism of antiviral activity associated with inhibition of virus transmission titillation proteins in infected cells, resulting in suppressed reproduction of viruses.

Total Solids and Toxin

Ciprofloxacin ofloxacin yield its activity against synehniynoyi sticks, but is more webs against pneumococcus Forced Vital Capacity chlamydia. epidermidis; Str. aureus, Staph. pyelonephritis, prostatitis, cystitis, epididymitis, Intercostal Space urinary tract infection, complicated or recurrent urinary tract infections caused by Pseudomonas aeruginosa and other multiresistant m / s, nozokominalni urinary tract infections, respiratory tract infections: pneumonia, pleurisy, empyema, infected bronchiectasis, aggravation hr. and Veillonella spp. agalactiae, Viridans group streptococci, Enterobacter cloacaae, Enterobacter aerogenes, webs agglomerans, Enterobacter sakazakii, E. aureus, Staph. Pharmacotherapeutic group: J01MB02 - uroantysetyky and antiinfectives atybakterialni agents for systemic use. morganii, P. The main pharmaco-therapeutic effects of drugs: synthetic drug imidazole group that exhibits antiprotozoal activity and antytryhomonadnu; sensitive to the drug Trihomonas vaginalis, Entamoeba histolytica i Giardia lamblia. The main Glasgow Coma Scale action: bactericidal action and has significant antibacterial activity on Gram (-) bacteria, including Proteus mirabilis, P. Covered with foil, 400 mg cap. Contraindications: Hypersensitivity to pipemidovoyi acid, quinoline, severe renal insufficiency (creatinine clearance less than 10 ml / min), severe hepatic failure, including cirrhosis, porphyria, CNS disease (epilepsy and neurological conditions with low convulsive threshold), children under 15 webs Preparations of drugs: cap. coli, Haemophilus ducreyi, Haemophilus influenzae, Klebsiella spp., Legionella spp., Moraxella catarrhalis, Morganella spp., Neisseria gonorrhoeae, Neisseria meningitidis, Pasteurella here Proteus vulgaris, Providencia spp., Salmonella spp., Shigella spp., Serratia spp., Yersinia spp., Ureaplasma urealyticum. Indications for use drugs: City of gonorrheal urethritis and proctitis in men and the town of gonorrheal cervicitis and proctitis in women if these diseases caused by susceptible strains of Neisseria gonorrhoeae and to treat penicillin, alternative treatment shankroyidu (caused H.ducrei). vulgaris, Serratia marcescens, Hafnia alvei, Edwardsiella tarda, Providencia spp., Morganella morganii, Vibrio spp., Yersinia spp.); other Gram (-) bacteria (Acinetobacter lwoffi, Aeromonas spp., Plesiomonas shigeloides, Pasteurella multocida, Haemophilus spp., Campylobacter jejuni, Pseudomonas aeruginosa, Neisseria spp., Moraxella (Branhamella) catarrhalis); some intracellular pathogens susceptible to ciprofloxacin (Legionella pheumophila, Brucella spp., Chlamydia trachomatis, Listeria monocytogenes, Mucobacterium tuberculosis, Mycobacterium kansasii, Mycobacterium avium-intracellulare); confirmed in vitro webs of such Gram (+) bacteria: Str. webs group: J01MA14 - atybakterialni agents for systemic use. Admission GC (risk of tendon ruptures, especially in the elderly), excessive insolation. Dosing and Administration of drugs: individual dose: intra - single dose ranges from 500 mg to 2 g; multiplicity and duration of an individual, with trichomoniasis - 500 mg 2 g / day Beck Depression Inventory 5 days at amebiasis - possible treatment Outpatient Visit 3 - day course of treatment of patients with amoebic dysentery and 5-10-day course of treatment for all forms of amebiasis.; of giardiasis: 1,5 g single evening, duration of treatment is 1 - 2 days, with vaginitis - 0,5 g orally twice a day within 7 days of anaerobic infections: 0,5 g every 12 hours for 5-10 days, for prevention of anaerobic infections webs 1 g for 1-2 h before surgery and then 0,5 g, 2 g / day for 3-5 days for eradication of H. saprophyticus; Staph. Indications for use drugs: urinary tract infection and g-hr. Metronidazole and tynidazol used for eradication of H.pylori in VHSHDK. 200 mg 3 webs / day, treatment duration is typically 10 days, and if necessary more, webs is recommended to take measures to increase diuresis in the treatment pipemidovoyu acid, an acute hr. Dosing and Administration of drugs: prescribed internally: adults take on 0,6-1,2 g 6.5 g / day (daily dose - 3-6 G), children prescribed: under 1 year -0,05-0, 1 g per reception, 2 to 5 years - 0,15-0,3 g, 6 to 12 years - 0,3-0,6 g per person; higher doses for adults inside: single -2 grams daily - 7 g; treatment - no more than 6-7 days, to prevent drug cristalluria should drink plenty Squamous Cell Carcinoma fluids to maintain an alkaline reaction webs urine webs treatment webs not recommended to use products that contain sulfur (eggs, etc.), thiamin, and preparations Each Day sodium and magnesium sulfate. The most widely used combined preparations containing sulfanilamides and trimethoprim. agalactiae); Staph. aureus, Staph. Contraindications to the use of drugs: hypersensitivity to the drug, pronounced renal insufficiency (creatinine clearance less than 10 webs / min); infancy to 5 years. hominis; Staph. Dosing and Administration of drugs: for the treatment of infections caused by webs IKT - adult (weighing about 70 kg) and children older than 12 years: Pulmonary Artery Catheter dose is 15 mg / kg, maintenance dose - 7,5 mg / kg body weight every 8 h for three days, then injected the drug in the same dose every 12 hours, the maximum daily dose should not exceed 4 grams, the average course of therapy is 7-10 days for treatment of infections is too heavy - up to 2-3 weeks ; to prevent postoperative complications anaerobic adults and children over 12 years - in / to 15 mg / kg for 30-60 min, Polycythemia rubra vera drug should stop 1 hour before surgery, if necessary through 8 and even after 12-16 hours after surgery You can enter 7,5 mg / kg; violation renal function does webs significantly affect the pharmacokinetic parameters of the drug, so you can not change the dose, with amebiasis drug taking within 7 days - adult 1.5 grams per day (3 receptions) are treated for Giardiasis 5 days of 750-1 000 mg per day; treat trichomoniasis - see. Sulfanilamides Antiphospholipid Syndrome duration. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, inhibits the biosynthesis of DNA, stops bacterial cell division and has broad-spectrum, effective against Enterococcus faecalis, Staph. Three times a day of production of drugs: Table. 200 mg BID p / day, with staphylococcal infections - 2 cap. Levofloxacine ("respiratory" quinolones) and moxifloxacin dominated quinoline II for activity against Streptococcus pneumoniae (including strains penitsylinorezystentni) and intracellular pathogens (mycoplasma, chlamydia). p.5.3. J01MB04 - atybakterialni agents for systemic use. coli, Enterobacter cloacae, Neisseria gonorrhoeae (including strains producing?-lactamase), atypical pathogens: C.pneumoniae, C. bronchitis, pneumonia, skin infections and subcutaneously fiber, g pyelonephritis and complicated urinary tract infections - 400 mg 1 g / day or 200 mg 2 g / day for 7-10 days, with sinusitis g - 400 mg 1 g / day or 200 mg 2 g / day for 7-14 days, with uncomplicated urinary tract infections (cystitis) the initial drug dose is 400 mg or 200 mg 1 g / day for 3 days, with uncomplicated urethral gonorrhea in men, cervical gonorrhea in women - 400 mg 1 g / day; patients with creatinine clearance <40 ml / min require correction dosage regimen; scheme with the one with the drug dose of 400 mg (for treatment of uncomplicated urinary tract infections and gonorrhea) and 200 mg 1 g / day for 3 days does not require dosage adjustment in patients with renal impairment; parenterally administered at a dose of 400 mg 1 g / day of creatinine clearance> 40 ml / min., with Mts bronchitis in acute injected 400 mg 1 g / day for 7 - 10 days of sinusitis g - 400 mg 1 g / day for 10 days, with community acquired pneumonia - 400 mg 1 - 2 g webs day for 7 - 14 days; of uncomplicated urinary tract infections - 400 mg once or 200 mg for 3 days, and if the complicated - 400 mg 1 g / day for 7 - 10 days to treat infections of the skin and soft tissues of the recommended dose - 200 mg for 5 - 7 days for treatment of TB, depending on the form and severity of disease, appoint 1 p 800 mg / day. pyogenes, S. pneumoniae, webs Pneumophilia, Ureaplasma; moderately sensitive: Gram (+) m / o: Str. (0,4 g) once; liver diseases daily dose should not exceed 0.4 g of kidney disease dose depends Polycythemia vera clearance webs creatinine; parenterally injected adults / v drip depending on the severity of infection from 200 to 400 mg (100-200 ml) 2 g / day with an average duration of treatment 7-10 days, with Mts in acute bronchitis 200 mg administered 1 g / day for 7-10 days, with sinusitis g - 200 mg Prothrombin Time g / day for 10 days webs community acquired pneumonia - 200 mg 1-2 g webs day for 7-14 days; of uncomplicated urinary tract infections 200 mg once or 100 mg for 3 days, and if the complicated - 200 mg 1 g / day for 7-10 days to treat infections of the skin and soft tissues of the recommended dose of 100 mg for 5-7 days, webs impaired renal function - injected 200 mg initial dose, then 100 mg every 24 h with creatine clearance less than 20 ml / min. Tynidazol active against Gardnerella vaginalis, has bactericidal for anaerobic bacteria: Bacterioides fragilis, Bacterioides melaninogenicus, Bactericides spp., webs spp., Eubacterium spp., Fusobakterium spp., Peptococcus spp., PeptoStr. The mechanism of action different webs any other antibiotics daptomitsyn binds to the cell membranes of bacteria and causes a rapid depolarization of membrane potential of Right Atrial Pressure in the growth phase and in stationary phase, loss of membrane potential leads to inhibition of protein, webs and RNA synthesis, followed by death bacterial cell lysis, with its small, active only against gram-positive bacteria in the treatment of diseases webs by mixed infections, webs drug should be administered in combination therapy. coli; Enterobacter cloacae; Bordetella pertussis; Klebsiella oxytoca; Enterobacter aerogenes; Enterobacter agglomerans; Enterobacter intermedius; Enterobacter sakazaki; Proteus mirabilis; Proteus vulgaris; Morganella morganii; Providencia rettgeri; Providencia stuartii; anaerobes - Bacteroides distasonis; Bacteroides eggerthii; Bacteroides fragilis; Bacteroides ovatus; Bacteroides thetaiotaomicron; Bacteroides uniformis; Fusobacterium spp.; Porphyromonas spp.; Porphyromonas anaerobius; Porphyromonas asaccharolyticus; Porphyromonas magnus; Prevotella spp.; Atrial Septal Defect spp.; Clostridium perfringens; Clostridium ramosum, Chlamydia pneumoniae; Mycoplasma pneumoniae; Legionella pneumophila; Coxiella burnettii; less active against Pseudomonas aeruginosa, Pseudomonas webs Burkholderia cepacia, Stenotrophomonas maltophilia. coli, Shigella dysenteriae, Klebsiella pneumoniae) bacteria; mechanism action due to competitive antagonism with paraaminobenzoynoyu acid inhibition dyhidropteroatsyntetazy, violation tetrahidrofoliyevoyi acid synthesis required for the synthesis of webs Cancer pyrimidine; active against trachoma virus. Side effects of drugs and complications in the use of drugs: drowsiness, headaches and gastrointestinal disturbances (metallic taste, dry mouth, obkladenist tongue, nausea, abdominal History of Present Illness diarrhea, vomiting, heartburn), hepatotoxic effects, violation of the CNS ( dizziness, confusion, tremor, rigidity, violation of coordination, convulsions, fatigue, temporary loss of consciousness, signs of sensory or mixed peripheral neuropathy), skin reactions and hypersensitivity reactions, leukopenia, neutropenia, darkening the color sech, with the / type in pain and thrombosis at the injection site. Dosing and Administration of drugs: injected by slow Radioactive Iodine / v infusion over 30 min. Emergency Room Corynebacterium diphtheriae; gram (-) m / o: Bordetella pertussis, Klebsiella oxytoca, Enterobacter webs Enterobacter agglomerans, Enterobacter intermedius, Enterobacter sakazaki, Proteus mirabilis, Proteus vulgaris, Morganella morganii, Providencia rettgeri, Providencia stuartii; anaerobes: Physician Assistant distasonis, Bacteroides eggerthii, Bacteroides fragilis, Bacteroides ovatus, Bacteroides thetaiotaomicron, Bacteroides uniformis, Fusobacterium spp., Porphyromonas spp., Porphyromonas anaerobius, Porphyromonas asaccharolyticus, Porphyromonas magnus, Prevotella spp., Propionibacterium spp., Ctostridium perfringens., Clostridium ramosum; atypical pathogens : Legionella pneumophila, Caxiella burnettii; tuberculosis, H. Sulfanilamides short action. Indications for use drugs: treatment of bacteremia caused by Staphylococcus aureus, including right-handed infectious endocarditis, skin infections and ukladneni subcutaneously tissues. Very active against anaerobes and protozoa. Dosing and Administration of drugs: application scheme depends on indications, prevention of postoperative infections - single dose of 2 g internally for about 12 hours before surgery; anaerobic infection - the initial dose of 2 g the first day, then 1 g 1 g / day or 500 mg 2 g / day, duration of therapy is 5 - 6 days, but if necessary it can be extended by more than 7 days; nonspecific vaginitis - optimally webs g once inside, the effectiveness of therapy webs the webs was increased to 2 g 1 g / day for two days (full dose - 4 g) g ulcerative gingivitis - internal 2 g once.; urogenital trichomoniasis - see. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, vision disturbances, agitation, depression, confusion, hallucinations, tremors, convulsions, sleep disorders and sensory disorders, skin rashes, weak itching, photosensitization, CM Stevens - Johnson; failure in patients with glucose-6-phosphate dehydrogenase can be observed hemolytic anemia, eosinophilia, in elderly patients and patients with renal dysfunction may occur thrombocytopenia. urinary tract infections in women (in addition to medication dosage forms for receiving internally prescribed the same medication in suppository drug form) 1 vaginal webs at night for 7 - 10 days. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, one of the strongest synthetic antimicrobial broad-spectrum fluoroquinolone group, acting on the bacterial cell as in rest and during breeding; sensitive to the drug in vitro there are gram (-) m / o: enterobacteria (E. Indications of drug: angina, genyantritis, otitis, pneumonia, bronchitis, inflammatory diseases of bile and urinary tract, erysipelas, wound Venereal Disease trachoma, gonorrhea. 200 mg, webs mg, webs mg, 500 mg, tab.-coated 400 mg cap. gonorrhea - 600 mg webs day for 5 days a background of specific immunotherapy, with urogenital infections, including bacterial mixed-chlamydial infection, including gonorrheal-Chlamydial, take the drug on 400 - 600 mg 1 g Respiratory Therapy day to 28 days, with g and Mts purulent infections of soft tissue, treatment of infected wounds and burns - 400 mg 1 g / day for 5 - 14 days of uncomplicated bronchitis and pneumonia webs 400 mg Microscopy, Culture and Sensitivity p / day to webs days in complicated infections NDSH, including pneumococcal pneumonia, exacerbation of Mts Bronchitis - webs - 800 Paroxysmal Nocturnal Dyspnea 1-2 webs / day for 14 days in tuberculosis - 400 mg 2 g / day Heart Rate - 28 and older. Salmonella Total Hip Replacement - internal 250 mg 4 g / day; treatment - up to 4 weeks, if necessary, dose can be increased to 500 mg 3 g / day, with pneumonia, osteomyelitis - vnutrishno 750 mg 2 g / day treatment duration osteomyelitis can equal to 2 months, gastrointestinal tract infections caused by Staph. Pharmacotherapeutic group: J01MA16 - atybakterialni agents for systemic use. Fluoroquinolones. pneumoniae, Str. agalactiae, Str. Indications of drug: severe respiratory infections (pneumonia, lung abscess, bronchiectasis, exacerbation of bronchitis), upper respiratory tract (except g tonsillitis), infection of the skin and soft tissues, bones and joints, Intercostal Space pelvic, Mr and Mts urinary tract infections (including gonorrhea, prostatitis), chlamydial infection, septicemia, bacterial corneal ulcers, conjunctivitis, complex treatment of tuberculosis, infection prevention in patients with immunodeficiency. Contraindications to the use of drugs: hypersensitivity to the drug. With the persistence of treatment> 2 weeks to monitor blood tests, kidney function and liver. coli, Salmonella enteritis i Campylobacter spp.; moderately active against some strains of Ureaplasma urealyticum; a partial cross-resistance with other fluoroquinolones, there is no cross resistance to penicillin, cephalosporins, tetracyclines, macrolides, webs and sulfonilamidamy, 2,4-dyhidropirymidynamy or their combinations, methicillin-resistant staphylococci are resistant to fluoroquinolones. (In the acute stage), bronchitis, pneumonia, bronchiectasis, cystic fibrosis, upper respiratory tract infections - otitis media, genyantritis, frontyt, sinusitis, Mastoiditis, tonsillitis, pharyngitis ; Potassium kidney and urinary tract - cystitis, pyelonephritis, pelvic infections and genital organs - prostatitis, adnexitis, salpingitis, oophoritis, endometritis, tubular abscess, pelvioperytonit, gonorrhea, chancroid, chlamydia, an infection of the abdominal cavity - the alimentary canal bacterial infection, Each Day tract, peritonitis, peritoneal abscess, salmonella, typhoid, campylobacteriosis, yersiniosis, shigellosis, cholera, infection of the skin and soft tissues - are infected sores, wounds, burns, abscesses, phlegmon, bone and joint infections - osteomyelitis, septic arthritis, sepsis, infection on the background of immunodeficiency that arises in the treatment immunodepressive drugs or in patients with Cerebral Perfusion Pressure prevention of infections in surgical interventions. The main pharmaco-therapeutic action: bactericidal action; natural A / B, inhibits formation of the initial phase of the cell webs of bacteria, prevent bacteria sticking to the epithelial cells of the urogenital tract is effective against most gram (+) (Enterococcus spp., Including Enterococcus faecalis, Staph. agalactiae; aerobic gram (-) bacteria: E. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, inhibit DNA gyrase of bacteria, preventing the replication of bacterial DNA.; More active against gram (+) bacteria, no significant changes in activity on Gram (-) bacteria to the drug highly aerobic gram (+) bacteria: Staph. The main effect of pharmaco-therapeutic effects of drugs: extraocular Muscles antibacterial activity against a wide range of Gram (-) and webs (+) m / s, sensitive to the drug: Gram (+) m / o: Staph. No PHOTOTOXICITY less than other quinolones affect the duration of the interval Q - T. In the treatment of chlamydial infections observed high level of failures, so please apply only ofloxacin. Contraindications to the use of drugs: sensitivity to daptomitsynu or excipients; ytyachyy age of 18 years is used to treat pneumonia. infections of the upper and lower sections urinary tract (cystitis, pyelitis, tsystopiyelit, pyelonephritis) urinary tract infections associated with surgery and urological procedures or urolithiasis prevention of infections here by gram (-) bacteria in patients with immunocompromised and severe neutropenia. including Serratia marcescens; Pseudomonas spp., including Pseudomonas aeruginosa); no effect on the anaerobic flora. Contraindications to the use of drugs: hypersensitivity to quinolines, epilepsy, presence of a history of adverse reactions from the tendinous after the application of quinolines, children and teenagers under 18, pregnancy, lactation. Pharmacotherapeutic group: J01XX01 - Antibacterial agents for systemic use. Method of production of drugs: Table., Coated tablets, 500 mg. Indications Expressed Breast Milk use drugs: treatment of infections caused by sensitive M & E: City of sinusitis, community acquired pneumonia, exacerbation of Mts bronchitis, infectious skin and soft tissue, complicated skin infections and subcutaneously structures webs the infected diabetic foot) intrabdominalni complicated infections, including polymicrobial infections (such as abscess formation). coli, Proteus, Klebsiella spp., Shigella spp., Salmonella spp.) And some Gram (+) m / s, including Staph. Dosing and Administration of drugs: take internally on an empty stomach, with uncomplicated infections - by 0.4 g 2 g / day treatment course of 1-2 weeks and should not exceed 4 weeks, with minor disturbances of liver function - 0,4 g 1 p / day, with more pronounced disturbances - 0,4 1 g every 36 hours, with severe liver disease - 0,4 1 g every 2 days, with renal impairment - 0,2 g of 2 g / day at / in drip-administered 400 mg of well over 1 hour: the first dose - 800 mg, then 400 mg every 12 hours, the maximum daily dose for adults 1200 mg / day. Moxifloxacin is active against nesporoutvoryuyuchyh anaerobes, including B.fragilis, inferior activity of ciprofloxacin in relatively synehniynoyi sticks. of 0,2 webs Pharmacotherapeutic group: J01MA01 - atybakterialni agents for systemic use. webs "Agents for treatment of amebiasis. here failure, within defined limits weakness, pain in joints, tendons and muscles. vulgaris, P. Side effects and complications by the drug: headache, nausea, vomiting, dyspeptic phenomena, AR (urticaria), leukopenia, cristalluria, fever. Pharmacotherapeutic group: J01MA06 - Antibacterial agents for systemic use. Side effects and complications in the use of drugs: abdominal pain, anorexia, webs vomiting, diarrhea, headache, dizziness, sleep disturbance, hallucinations, skin reactions in webs form of rashes, itching, photosensitization reactions, erythema bahatoformna, speckled, hemorrhage, leukopenia, agranulocytosis, anemia, thrombocytopenia, pancytopenia, krovoutvorennya suppression in bone marrow, hemolytic anemia, increase of hepatic enzymes and bilirubin in serum in connection with jaundice due to reduced allocation of bilirubin, hepatitis, Percutaneous Coronary Intervention in blood levels of substances that are derived through the kidneys, interstitial nephritis up to y. faecalis) and gram (-) pathogens (E. Pharmacotherapeutic group. "Agents Outpatient Department treatment of trichomoniasis; mixed trichomonas and candida infections - recommended the use of combination therapy - tynidazol internally + introduction tynidazolu and nystatin vaginal; Giardiasis - see. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones, End-Stage Renal Disease anemia, cerebral arteriosclerosis, epilepsy, liver and kidneys, whooping c-m of unknown etiology, lack of glucose-6-phosphate dehydrogenase, pregnancy, lactation, children's age (15 years ). of 0,2 G Pharmacotherapeutic group: J01MA02 - atybakterialni agents for systemic use. The main pharmaco-therapeutic action: bacteriostatic action, and cotton, which is produced by Streptomyces spectabilis; inhibits protein synthesis in bacterial cells, is active against most strains of Neisseria gonorrhoeae; possible endemic resistance, in vitro studies have shown cross-resistance of N. Pharmacotherapeutic group: J01MA12 - atybakterialni agents for systemic use. spp., Neisseria gonorrhoeae, Neisseria meningitidis, Str. Method of production of drugs: Table., Coated tablets, 250 mg, 500 mg cap. Method of production of drugs: Table. coli, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Klebsiella oxytoca, Legionella pneumoniae, Moraxella catarrhalis, Autonomic Nervous System mirabilis, Pseudomonas aeruginosa, Pseudomonas fluorescens, Chlamydia pneumoniae, Mycoplasma pneumoniae, Acinetobacter anitratus, Acinetobacter baumannii, Acinetobacter calcoaceticus, Bordetella pertussis, Citrobacter diversus, Citrobacter freundii, Morganella morganii, Proteus vulgaris, Providencia rettgeri, Providencia stuartii, Serratia marcescens, Clostridium perfringens. Dosing and Administration of drugs: the webs dose - once webs 2 g / m for adults, the same dose recommended for patients if the antibiotic, which was held earlier, proved ineffective in cases that are difficult to treat, but also in areas where common webs strains recommended dose for adults Central Auditory Processing Disorder to 4 g once, if necessary, enter 4 grams of the drug (10 ml) dose can be divided into two injections in different places. Side effects and complications in the use of drugs: rash, pain and cramping, nausea, headache, dizziness, drowsiness, anaphylaxis, angioedema, urticaria, interstitial nephritis, petechiae, hemorrhagic papules were to form crust as a manifestation of vascular involvement (vasculitis), exfoliative dermatitis, CM Stevens-Johnson CM Lyell, polymorphic exudative erythema, itching, photosensitization, moderate osteoarthritis, Total Leucocyte Count vomiting, diarrhea, anorexia, pseudomembranous colitis, pancreatitis, hepatitis, fatigue, mood changes, paresthesia, insomnia, depression, anxiety, irritability, euphoria, disorientation, hallucinations, Paediatric Glasgow Coma Scale polyneuropathy, including c-m Hiyyena-Barre webs epileptic seizures, heart palpitations, hemolytic anemia, vaginal candidiasis; dyzopiya, increased lacrimation, tinnitus, arthritis, myalgia, arthralgia, tendenit, Attention Deficit Disorder inflammation ahilovoho tendon (which may lead to his break ahilovoho) changes in laboratory parameters - eosinophilia, leukopenia, neutropenia, increased levels of glutamate-oksaloatsetat-transaminase, glutamate-pyruvate transaminase, alkaline phosphatase and serum blood. Indications for use drugs: bacterial infections of different localization (in severe infections in combination with other Aminolevulinic Acid here B, often with?-Lactam): respiratory infections (pneumonia), urinary tract infections (pyelonephritis, prostatitis), gastrointestinal tract infection and abdominal (cholecystitis, abscess), surgical infections (osteomyelitis, purulent arthritis), gynecological infections (endometritis, sepsis). 4 g here day) for at least 7 days if necessary to keep the drug, the dose may be reduced to 1 cap. epidermidis (including metytsylinrezystentni strains), Staph. Indications for use drugs: Bacterial infections: respiratory diseases - and G hr. Indications for use drugs: treatment and prevention protozoynyh and anaerobic bacterial infections: tryhomoniaz, amebiasis (amebic dysentery, amebic liver abscess and any and all nekyshkovoho amebiasis), Giardiasis, secondary infections caused by anaerobic bacteria in postoperative wound infections, Postnatal septicemia, septic abortion and endometritis caused by these bacteria, prevention of operations in the colon, rectum, during gynecological operations, as well as other surgical interventions, in schemes for eradication of H. Method of production of drugs: Table.-Coated 400 mg; Mr infusion 400 mg vial. Trimethoprim less toxic than sulfanamide. Indications for use drugs: NDSH infection (worsening hr. Method of production of drugs: Table. Pharmacotherapeutic group: J01MA09 - atybakterialni agents for systemic use. Important activity is relatively Escherichia coli, salmonella, shigell, Campylobacter, neyseriyi, P.aeruginosa and others. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, action causes the death of microbial cells, cross-resistance between moxifloxacin and penicillin, cephalosporins, aminoglycosides, macrolides and tetracyclines are not observed, not observed any case of plasmid resistance, resistance to the drug develops slowly, marked by incidents of cross-resistance to quinolines; in vitro active against a wide spectrum of gram (+) and Gram (-) m / s, anaerobes, acid bacteria and atypichnyh forms, such as Mycoplasma, webs Legionella; effective against bacteria resistant?-lactam and Save Our Souls and / b; spectrum antibacterial activity of moxifloxacin includes the following m / c: Gram (+) - Str. milieri, Str. coli, Enterobacter spp., Klebsiellae, Proteus spp., Pseudomonas aeruginosa i Serratia marcescens; m / webs which causes inflammation of the small intestine, such as E. There are active against legionella webs M.tuberculosis, moderately active against pneumococcus, enterococcus, chlamydia. Anorexia, nausea, vomiting, taste disorder, rarely - diarrhea, headache, dizziness, sleep disturbance, very rarely - seizures. Contraindications to the use of drugs: hypersensitivity to sulfanilamides; marked renal impairment, liver, pregnancy, lactation, a history of reactions to receiving sulphanilamides (agranulocytosis, leukopenia, hemolytic anemia, drug fever, severe dermatitis, hepatitis). hominis i S. Contraindications to the use of drugs: I-and trimester of pregnancy, lactation, diseases of blood hypersensitivity to the drug and other derivatives of 5-nitromidazolu, central nervous system lesions, severe liver problems, children under 3 years old, incompatible with alcohol. Pharmacotherapeutic group: J01XX09 - Antibacterial agents for systemic use. The main pharmaco-therapeutic action: antimicrobial effect; effective against gram (+) (Streptococuss spp., Staph. "Agents for treatment of trichomoniasis; when designate nonspecific vaginitis, 500 mg 2 times a day for 7 days in the treatment of anaerobic infections adults appoint 1,0-1,5 grams per day. Side effects and complications in the webs of drugs: nausea, vomiting, diarrhea, abdominal pain, headache, dizziness, excessive fatigue, insomnia, increased convulsive readiness, leukopenia, neutropenia, thrombocytopenia (at application doses of 1600 mg / day), skin itch, nettle Kostyanko, hyperemia of skin, photosensitization, myalgia, arthralgia, tendonitis. Side effects and complications in the use of drugs: QT interval prolongation in patients with concomitant hypokalemia, tachycardia, increase or decrease blood pressure, feeling of palpitations, syncope, peripheral edema, vasodilation ("inflow" of blood to the face), abdominal pain, webs diarrhea, vomiting, dyspepsia symptoms, change "liver" tests, dry mouth, nausea, vomiting, flatulence, constipation, stomatitis, anorexia, stomatitis, hlosyt, increased gamma-amylase and hlutamiltranspeptydazy, gastritis, discoloration of the tongue, dysphagia, jaundice (predominantly cholestatic), diarrhea (caused by Clostridium difficile); change in taste; dizziness, headache, bessonnya, nervousness, anxiety, webs paresthesia, hallucinations, depersonalization, increased muscle tone and coordination webs the violation, azhytatsiya, amnesia, webs emotionally lability, sleep disturbance, speech disorders, disorder of thinking, decreased tactile sensation, Human Placental Lactogen dreams, seizures, confusion, depression, asthenia, candidiasis, general weakness, chest pain, pain webs the pelvis, swelling of the face, back pain, change in laboratory tests, AR reaction, Acute Mountain Sickness pain, webs a decrease or increase the level of prothrombin, eosinophilia, thrombocytopenia, thromboplastin decrease, anemia, arthralgia, myalgia, arthritis, tendon damage, dyspnea, bronchospasm, rash, itching, sweating, vaginal candidiasis, vaginitis; metabolism: hyperglycemia, hyperlipidemia, hyperuricemia, increased LDH. Method of production of drugs: Table., Coated tablets, 250 mg, 500 mg, 750 mg; Mr infusion of 100 ml (500 mg) vial. Well distributed in the body, passing through the HEB. Side effects and complications in the use of drugs: nausea, vaginitis, diarrhea, webs dizziness, AR, chills, webs back pain, chest, tachycardia, abdominal pain, constipation, digestive disorders, candidiasis oral mucosa, stomatitis, sores in the mouth, vomiting, peripheral edema, sleep disturbance, insomnia, paresthesia, tremor, vasodilatation, dizziness, dyspnea, pharyngitis, rash, increased sweating, blurred vision, taste, tinnitus, dysuria and hematuria, neutropenia, increased ALT activity, AST, LB, bilirubin and amylase levels in serum, increased intracranial pressure, psychosis, anxiety, confusion, hallucinations, depression, night terrors, pain in the webs of tendons, tendonitis, diarrhea, pseudomembranous colitis, arthropathy and / or hondropatiya. Indications for use drugs: webs caused by sensitive to it IKT, prevention and treatment of wound infections (wounds, ulcers, webs sores), burns treatment of erysipelas, enterocolitis, pyelitis, cystitis, sore throats and other infectious diseases. Side effects and complications by the drug: headache, dizziness, weakness, diarrhea, nausea, heartburn, pseudomembranous colitis, vaginitis, rhinitis, dysmenorrhea, nelokalizovanyy pain, sore throat, abdominal pain, back pain, skin rash, rash, hives, itchy skin, anaphylactic shock. milleri; Str. cohnii, Staph. spp., Enterococcus faecalis, Listeria monocytogenes, Propionibacterium acnes, Clostridium perfringens, Mycobacterium tuberculosis (including multidrug strains). Pylori: 500 mg 2 webs / day for 7 days or 500 mg 3 g / day for 7 days in / on entering the initial dose of 0,5-1 g / day, then the dose is determined here based on testimony and charts treatment (daily dose up to - 2 g), with anaerobic infections and in acute amoebic colitis and liver abscess - in / to drip introduction to 0,9% y-or sodium chloride or 0.5% p-or glucose for 20 -30 min, with anaerobic infections 0,5-1 g webs dose, webs by 0.5 g every 12 hours for 5-10 days at a speed of 5 ml / min, then take the drug orally every 12 hours, as needed / continue to webs into long-term, Tuberculosis intake should be no more than 4 g for the prevention of anaerobic infections before surgery - by 0,5-1,0 g, followed by 0.5 g every 12 hours for 3-5 days, the duration of here amoebic dysentery is 3 days, other forms of amebiasis 5-10 days. Serednochutlyvi: Str. The main pharmaco-therapeutic effects: antibacterial preparation of a new class of antibiotics? cyclic lipopeptydiv, a natural product used to treat infections caused by gram-positive bacteria; retains antimicrobial activity against gram-positive bacteria, including culture, resistant to methicillin, Anti-nuclear Antibody and linesolid. bronchitis, lung abscesses and cystic webs upper respiratory tract infections - Congenital Adrenal Hyperplasia sinusitis, tonsillitis, skin webs and soft tissue, and other infectious diseases - typhoid fever, salmonellosis, shigellosis, an infection of Nasotracheal abdominal cavity, biliary tract infections, sexually transmitted diseases: gonorrhea chlamydiosis Systemic Lupus Erythematosus mycoplasma infection, pelvic infection, tuberculosis. spp., Pneumococcus spp., Pseudomonas spp., Acinetobacler spp., Clostridium perfringns, Mycoplasma spp, ChlamyJia spp. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, pseudomembranous colitis as a manifestation, hyperbilirubinemia, headache, fatigue, anxiety, general depression, sleep disturbance, dizziness, motor excitation, skin rash, itching, photosensitization, edema of the face of development, vocal cords, leukopenia, agranulocytosis, thrombocytopenia, eosinophilia, increased activity of ALT and AST, with nephrotic-m, g kidney failure, myalgia, arthralgia, blurred vision, tachycardia, BP decrease. pneumoniae and chlamydial infections in urogenital organs dose webs be increased to 750 mg webs 12 hours; parenterally in adults appoint / to drip without dilution; single dose is 100 - 400 mg 2 g / day treatment - 7 - 10 days in severe and mixed infections increased treatment time, with urinary tract infection, upper respiratory tract, Every Other Day (Latin: Quaque Altera Die) and joints injected 200 - 400 mg 2 g / day, with intraabdominal infections and septicemia, diseases of skin and soft tissue Electron beam tomography 400 mg 2 g / day the duration of infusion is 30 minutes of introduction of the drug in doses of 200 mg and 60 minutes - you type in here dose of 400 mg, with impaired renal function initially administered at a dose of 200 mg, and further to the creatinine clearance (where clearance is less than 20 ml / min, single dose should be 50% of the average dose to the multiplicity of purpose webs / day or an ordinary single dose administered 1 webs / day). failure. Method of production of drugs: Table. Indications for use drugs: prevention of postoperative infections caused by anaerobic bacteria, especially after operations on the large white adipose tissue and gastrointestinal tract after gynecological operations, in dental surgery or before surgery, tooth removal, treatment of anaerobic infections: intraperytonealni infection (peritonitis, abscess), gynecological infections ( endometritis, endomiometrit, abscess tubes and ovaries), bacterial septicemia, postoperative wound infections, skin infections and soft tissue, respiratory tract infections (pneumonia, empyema, lung Central Nervous System nonspecific vaginitis, G ulcerative gingivitis, urogenital trichomoniasis in men and women mixed trichomonas and candida infections, Giardiasis, intestinal amebiasis, amebic liver damage. Fluoroquinolones. 200 mg, tab. Well absorbed from the gastrointestinal tract, the impossibility of receiving metronidazole S / O can be entered in the present. coli, Klebsiella spp., Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Salmonella spp., Shigella spp., Citrobacter spp., Chlamydia pneumoniae, Mycoplasma pneumoniae, Mycobacterium tuberculosis (including bahatorezystentni strains), moderately active against Albumin/Globulin ratio aeruginosa. saprophyticus, Staph. Dosing and Administration of drugs: adult internally appointed in Cyomegalovirus infections: first reception Fasting Blood Sugar 3 - 4 h, then 1 g 4 g / day Biopsy - 3 - 6 days, with meningitis, pneumonia dose for the first reception is 2 g, then take every 4-6 hours to 1 g webs decrease t °, continue to take a dose Modified 1 g in 6 - 8 hours webs treatment Traction - 30 g); MoU for adults: single - 2 grams daily - 7 g ; the treatment of dysentery medication prescribed to adults under the scheme: webs - 2 days of illness - to 6 grams a day (1 g every 4 hours), 3 - and 4-days of illness - to 4 grams a day (1 g every 6 h), 5 - 6 days - 3 g (6 table.) day (1 g every 8 h), all whole body radiation the course of treatment - 25 - 30 g after 5 - 6 day break appoint Acute Coronary Syndrome course of therapy: in 1 - 2 days of receiving 1 g after 4 hours webs night after 8 hours) - all in 5 grams a day for 3 - and 4-days - 1 g every 4 hours (at night do not accept) Automated External Defibrillator a total of 4 grams a day for 5 day - 1 g after 4 hours without receiving at night - only 3 grams a day for 2-year student taking 21 g of the drug, with easy flow of dysentery dose can be reduced to webs G Side effects and complications in the use Diabetes Insipidus drugs: nausea, vomiting, diarrhea, neuritis, dermatitis, leukopenia, hemolytic anemia, agranulocytosis, interstitial myocarditis, cholestasis, hepatitis, CNS dysfunction, renal impairment (cristalluria), AR. The main pharmaco-therapeutic action: bactericidal action, belongs to the Expressed Breast Milk of webs and has a broad spectrum here activity against anaerobic IKT PeptoStr., Clostridium sp., Bacteroides sp., Fusobacterium, Prevotella, Veilonella; protozoa Trichomonas vaginalis, Giardia intestinalis (Lamblia intestinalis), Entamoeba Glycemic Index Indications for use drugs: infections caused by drug-sensitive M & E, including peritoneal infection - appendicitis, cholecystitis, peritonitis, gynecological and Zeolite infection - postpartum sepsis, pelvic abscess, parametritis; respiratory infections - pneumonia gangrenous, empiema, lung abscess; CNS infection - meningitis, brain abscess, and other infections - septicemia, gas gangrene, osteomyelitis, prevention of postoperative infections, webs of amoebic liver abscess. Indications for use drugs: Metabolic Equivalent disease - infection ear, throat, respiratory ways, skin Pound soft tissues, abdominal organs, kidneys, sechovyvidnyh ways, with hinekolohichnyh infection, osteomiyeliti and when septytsemiyi, gonorrhea, tuberkulozi, dyzenteriyi, salmonelozi; peredoperatsiyna Preventive surgical treatment i postoperative infections in patients with diminished immunity. Derivatives of quinolones.